Evidence map›Paper›PMID 30953537›Full record

ArticleStem cell research & therapy2019

Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration through synergistic action of extracellular vesicle cargo and soluble proteins.

Robert Mitchell, Ben Mellows, Jonathan Sheard, Manuela Antonioli, Oliver Kretz, David Chambers, Marie-Theres Zeuner, James E Tomkins, Bernd Denecke, Luca Musante and 9 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 218 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Adipose-Derived Extracellular Vesicles and Intercellular Crosstalk With Skeletal Muscle: Implications for Sarcopenic Obesity and Metabolic Dysregulation.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 7 countries.

Robert MitchellSchool of Biological Sciences, University of Reading, Reading, UK.
Ben MellowsSchool of Biological Sciences, University of Reading, Reading, UK.
Jonathan SheardStem Cell Biology and Regenerative Biology Group, School of Pharmacy, University of Reading, Reading, UK.
Manuela AntonioliI.N.M.I. L Spallanzani IRCCS, Rome, Italy.
Oliver KretzDepartment of Medicine III, Faculty of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
David ChambersWolfson Centre for Age-Related Diseases, King's College, London, UK.
Marie-Theres ZeunerStem Cell Biology and Regenerative Biology Group, School of Pharmacy, University of Reading, Reading, UK.
James E TomkinsStem Cell Biology and Regenerative Biology Group, School of Pharmacy, University of Reading, Reading, UK.
Bernd DeneckeInterdisciplinary Centre for Clinical Research Aachen, RWTH Aachen University, Aachen, Germany.
Luca MusanteCentre for Bioanalytical Sciences (CBAS), Dublin City University, Dublin, Ireland.
Barbara JochDepartment of Neuroanatomy, Institute for Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Florence Debacq-ChainiauxURBC, Namur Research Institute for Life Science (NARILIS), University of Namur, Namur, Belgium.
Harry HolthoferCentre for Bioanalytical Sciences (CBAS), Dublin City University, Dublin, Ireland.
Steve RayMicregen, Alderley Edge, Manchester, UK.
Tobias B HuberDepartment of Medicine III, Faculty of Medicine University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Joern DengjelFRIAS Freiburg Institute for Advanced Studies, University of Freiburg, Freiburg, Germany.
Paolo De CoppiStem Cells & Regenerative Medicine Section, UCL Great Ormond Street Institute of Child Health, London, UK.
Darius WideraStem Cell Biology and Regenerative Biology Group, School of Pharmacy, University of Reading, Reading, UK. d.widera@reading.ac.uk.ORCID 0000-0003-1686-130X
Ketan PatelSchool of Biological Sciences, University of Reading, Reading, UK. ketan.patel@reading.ac.uk.
University of Reading · GBUniversity of Freiburg · DEUniversität Hamburg · DEDublin City University · IEGNS Healthcare (United States) · USGreat Ormond Street Hospital · GBIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITKing's College London · GBRWTH Aachen University · DEUniversity of Fribourg · CHUniversity of Namur · BE

Funding

Biotechnology and Biological Sciences Research Council BB/I015787/1Biotechnology and Biological Sciences Research Council BB/L0677X/1
6 · The paper itself

Abstract

backgroundThe mechanisms underpinning the regenerative capabilities of mesenchymal stem cells (MSC) were originally thought to reside in their ability to recognise damaged tissue and to differentiate into specific cell types that would replace defective cells. However, recent work has shown that molecules produced by MSCs (secretome), particularly those packaged in extracellular vesicles (EVs), rather than the cells themselves are responsible for tissue repair.

methodsHere we have produced a secretome from adipose-derived mesenchymal stem cells (ADSC) that is free of exogenous molecules by incubation within a saline solution. Various in vitro models were used to evaluate the effects of the secretome on cellular processes that promote tissue regeneration. A cardiotoxin-induced skeletal muscle injury model was used to test the regenerative effects of the whole secretome or isolated extracellular vesicle fraction in vivo. This was followed by bioinformatic analysis of the components of the protein and miRNA content of the secretome and finally compared to a secretome generated from a secondary stem cell source.

resultsHere we have demonstrated that the secretome from adipose-derived mesenchymal stem cells shows robust effects on cellular processes that promote tissue regeneration. Furthermore, we show that the whole ADSC secretome is capable of enhancing the rate of skeletal muscle regeneration following acute damage. We assessed the efficacy of the total secretome compared with the extracellular vesicle fraction on a number of assays that inform on tissue regeneration and demonstrate that both fractions affect different aspects of the process in vitro and in vivo. Our in vitro, in vivo, and bioinformatic results show that factors that promote regeneration are distributed both within extracellular vesicles and the soluble fraction of the secretome.

conclusionsTaken together, our study implies that extracellular vesicles and soluble molecules within ADSC secretome act in a synergistic manner to promote muscle generation.

Indexed as

AnimalsCell DifferentiationCell LineCell ProliferationExtracellular VesiclesGene Expression Regulation, DevelopmentalHumansInflammationMesenchymal Stem CellsMiceMicroRNAsMuscle, SkeletalProteinsProteomeRegenerationSolubilityMicroRNAsProteinsProteomeAdipose-derived mesenchymal stem cellExtracellular vesiclesInflammationmicroRNAMuscleProteomicRegenerationSecretome

Identifiers

PMID30953537
PMCPMC6451311
OpenAlexW2930319490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.